Vanucizumab (Synonyms: Anti-Human VEGFA Recombinant Antibody; RO5520985) |
| カタログ番号GC70111 |
Vanucizumabは、VEGF-Aと血管新生因子-2（Ang-2）およびそれらの受容体間の相互作用を同時に阻害する画期的な二重特異性IgG1モノクローナル抗体です。 Vanucizumabには、抗血管新生効果と抗癌作用があります。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1448221-05-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Vanucizumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Vanucizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *